サイケデリックは細胞内5-HT2A受容体の活性化によって神経可塑性を促進する
Maxemiliano V Vargas1,2, Lee E Dunlap2,3, Chunyang Dong4
1Neuroscience Graduate Program, University of California, Davis, Davis, CA 95618, USA.
まとめ
サイケデリックはセロトニンそのものとは異なり,細胞内5ヒドロキシトリプトミン (セロトニン) 2A受容体 (5-HT2ARs) を活性化することで,脳の可塑性を促進する. この発見は,細胞内5HT2ARを神経精神疾患の新たな治療標的として強調しています.
科学分野:
- 神経科学
- 薬理学について
- 分子生物学
背景:
- 皮質の dendritic 脊椎の密度の低下は神経精神疾患の特徴です.
- サイケデリックの治療効果は 皮質の神経の成長と可塑性を促進することと関連しています
- この可塑性には,5 - ヒドロキシトリプタミン (セロトニン) 2A受容体 (5 - HT2ARs) の活性化が不可欠である.
研究 の 目的:
- サイケデリックが神経可塑性を 促進するメカニズムを調査する
- 特定の5-HT2ARアゴニストのみが神経可塑性を誘発する理由を明らかにする.
- 5-HT2ARシグナル伝達における受容体の位置の役割を明らかにする.
主な方法:
- 分子や遺伝子のツールを使いました
- 細胞内5HT2AR信号伝達経路を調査した.
- 5-HT2ARsに対するセロトニンとサイケデリックアゴニストの効果を比較した.
主要な成果:
- 細胞内5HT2ARが 精神薬の可塑性促進効果を媒介することを示した.
- セロトニンが似たような可塑性メカニズムを誘導しないことが示され,その異なる効果が説明される.
- 5-HT2ARシグナル伝達における受容体の位置バイアスの重要性を強調した.
結論:
- 細胞内5HT2ARは,サイケデリック誘発の皮質の可塑性の主要な媒介者です.
- 神経精神疾患の潜在的治療標的として細胞内5-HT2ARsを特定した.
- セロトニンは皮質内の細胞内5-HT2ARsの内生リガンドではないことを示唆している.
関連する概念動画
CNS Stimulants: Psychedelic Agents
207
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
207
Neuroplasticity
648
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
648
Hallucinogens and Psychedelics
231
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
231
Drugs Affecting Neurotransmitter Synthesis
1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K


